Health Condition 1: H049- Disorder of lacrimal system, unspecified
Conditions
Interventions
Intervention1: Nux moschata in 6CH (centesimal
potency) with concomitant care: Intervention is planned as administering Nux moschata 6CH once daily for 4 weeks. Each dose will consist of 4 cane sugar
Sponsors
The Calcutta Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years. 2. Participants of either sex or transgender. 3. Participants providing written informed consent voluntarily. 4. Diagnosed dry eye disease patients using the Ocular Surface Disease Index (OSDI) questionnaire with values ranging from 13 to 32. 5. Adequate similarity with the symptomatology of Nux moschata, as decided by the homeopathic doctor
Exclusion criteria
Exclusion criteria: 1. Subjects diagnosed to have severe dry eye (OSDI greater than 32). 2. Subjects who have used contact lenses within the last 6 months. 3. Subjects who are on treatment with other artificial tear products, other topical drops or previously diagnosed with other ocular diseases. 4. Subjects with active or untreated malignancy or recovered from malignancy. 5. Vulnerable population: unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 7. Pregnant and puerperal women, lactating mothers. 8. Self-reported immune-compromised state. 9. Substance abuse and/or dependence. 10. Already undergoing homeopathic treatment for chronic disease within the last 6 months. 11. Simultaneous participation in any other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tear production values in both eyes using Schirmer’s test strips without the use of topical anaesthesiaTimepoint: At baseline, and every week, up to 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Participants self-administered Ocular Surface Disease Index (OSDI) questionnaireTimepoint: At baseline, and every week, up to 4 weeks. | — |
Countries
India
Contacts
Public ContactBhiswadeb Das
The Calcutta Homoeopathic Medical College and Hospital
Outcome results
None listed